Eaton Vance Management Innoviva, Inc. Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Innoviva, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 82,768 shares of INVA stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,768
Previous 82,920
0.18%
Holding current value
$1.5 Million
Previous $1.22 Million
21.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INVA
# of Institutions
240Shares Held
77MCall Options Held
53.9KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$174 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$132 Million39.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$114 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$113 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.92MShares$88.9 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.26B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...